Author:
Whitworth Hilary,Amankwah Ernest K.,Betensky Marisol,Castellucci Lana A.,Cuker Adam,Goldenberg Neil A.,Male Christoph,Rinzler Elliot,Zia Ayesha,Raffini Leslie
Reference31 articles.
1. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial;Male;Lancet Haematol,2020
2. DIVERSITY Trial Investigators. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial;Halton;Lancet Haematol,2021
3. PREVAPIX-ALL: apixaban compared to standard of care for prevention of venous thrombosis in paediatric acute lymphoblastic leukaemia (all)--rationale and design;O’Brien;Thromb Haemost,2019
4. Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease;Portman;J Am Coll Cardiol,2022
5. Thromboprophylaxis for children post-fontan procedure: Insights from the UNIVERSE study;McCrindle;J Am Heart Assoc,2021